ArticleMolecular cancer research : MCR2017

Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression.

Muralidharan Anbalagan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.